Impaired brain glymphatic flow in experimental hepatic encephalopathy

• Published in: Journal of hepatology Vol. 70; no. 1; pp. 40 - 49
• Main Authors: Hadjihambi, Anna, Harrison, Ian F., Costas-Rodríguez, Marta, Vanhaecke, Frank, Arias, Natalia, Gallego-Durán, Rocío, Mastitskaya, Svetlana, Hosford, Patrick S., Olde Damink, Steven W.M., Davies, Nathan, Habtesion, Abeba, Lythgoe, Mark F., Gourine, Alexander V., Jalan, Rajiv
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.01.2019; Elsevier Science Ltd
• Subjects: Animals; Aquaporin 4; Aquaporin 4 - metabolism; Bile; Bile acids; Bile ducts; Brain - diagnostic imaging; Brain - metabolism; Brain - physiopathology; Cerebrospinal Fluid - metabolism; Cirrhosis; Cognitive ability; Cortex (olfactory); Disease Models, Animal; Glymphatic system; Glymphatic System - metabolism; Glymphatic System - physiopathology; Hepatic encephalopathy; Hepatic Encephalopathy - diagnosis; Hepatic Encephalopathy - metabolism; Hepatic Encephalopathy - physiopathology; Immunofluorescence; Intracranial Pressure; Liver cirrhosis; Liver diseases; Magnetic Resonance Imaging; Male; Mass spectrometry; Mass spectroscopy; MRI; Olfactory bulb; Prefrontal cortex; Rats; Rats, Sprague-Dawley; Solutes; Glymphatic system; Cirrhosis; MRI; Mass spectrometry; Hepatic encephalopathy
• ISSN: 0168-8278; 1600-0641
• DOI: 10.1016/j.jhep.2018.08.021

[Display omitted] •Accumulation of noxious metabolites in the interstitial fluid of brain may contribute to hepatic encephalopathy.•Accumulation of such products may be due to reduced glymphatic clearance mechanisms in the brain.•We identified regions of impaired glymphatic clearance function, which aligned closely with cognitive/behavioural deficits.•Reduced AQP4 expression was observed in the same regions.•Altered AQP4 mediated glymphatic dysfunction may contribute to pathogenesis of hepatic encephalopathy. Neuronal function is exquisitely sensitive to alterations in the extracellular environment. In patients with hepatic encephalopathy (HE), accumulation of metabolic waste products and noxious substances in the interstitial fluid of the brain is thought to result from liver disease and may contribute to neuronal dysfunction and cognitive impairment. This study was designed to test the hypothesis that the accumulation of these substances, such as bile acids, may result from reduced clearance from the brain. In a rat model of chronic liver disease with minimal HE (the bile duct ligation [BDL] model), we used emerging dynamic contrast-enhanced MRI and mass-spectroscopy techniques to assess the efficacy of the glymphatic system, which facilitates clearance of solutes from the brain. Immunofluorescence of aquaporin-4 (AQP4) and behavioural experiments were also performed. We identified discrete brain regions (olfactory bulb, prefrontal cortex and hippocampus) of altered glymphatic clearance in BDL rats, which aligned with cognitive/behavioural deficits. Reduced AQP4 expression was observed in the olfactory bulb and prefrontal cortex in HE, which could contribute to the pathophysiological mechanisms underlying the impairment in glymphatic function in BDL rats. This study provides the first experimental evidence of impaired glymphatic flow in HE, potentially mediated by decreased AQP4 expression in the affected regions. The ‘glymphatic system’ is a newly discovered brain-wide pathway that facilitates clearance of various substances that accumulate in the brain due to its activity. This study evaluated whether the function of this system is altered in a model of brain dysfunction that occurs in cirrhosis. For the first time, we identified that the clearance of substances from the brain in cirrhosis is reduced because this clearance system is defective. This study proposes a new mechanism of brain dysfunction in patients with cirrhosis and provides new targets for therapy.